Current Issue

View Larger Image

Past Issues Adlink Subscription Visit Our Publisher

ADVERTISEMENT



Top Keywords




GEN podcasts

*Podcasts play in a pop-up window. Please make sure your pop-up blocker is off.

GEN’s editor in chief, John Sterling, interviews life science academic and biotech industry leaders on important research, technology, and trends. These podcasts will keep you informed with all the important details you need.

BIOTECHNOLOGY IN SPAIN

4/2/2010

- Interview with José María Fernández Sousa-Faro, Ph.D., President of the Spanish Association of Bioenterprises (ASEBIO), and Chairman of the Zeltia Group

Sponsored by the Trade Commission of Spain

The biotechnology industry in Spain has grown rapidly over the last decade. The country's life science business and academic sectors are major European players in carrying out R&D, creating spin-offs, and engaging in a wide range of collaborations. Spain is particularly accomplished in biomedicine. During this week's Podcast, Dr. José María Fernández Sousa-Faro discusses the current state of biotechnology in Spain and the country's plans for growing the bioindustry well into the future. He describes the activities of some of the key members of the Spanish Association of Bioenterprises and talks about the research and product development efforts of the biotech companies belonging to the Zeltia Group. Dr. Fernandez also details the most important strengths of the biotech industry in Spain and lists a few of the roadblocks that need to be overcome before the Spanish bioindustry can reach its full potential.

Dr. José María Fernández Sousa-Faro is President of the Spanish Association of Bioenterprises (ASEBIO), and Chairman of the Zeltia Group


Related content

GEN News Highlights

MORE RELATED GEN NEWS HIGHLIGHTS

Insight & Intelligence™

MORE RELATED INSIGHT & INTELLIGENCE™

GEN Articles

MORE RELATED GEN ARTICLES

BLOG biotech

MORE RELATED BLOG BIOTECH

GEN Podcasts

MORE RELATED GEN PODCASTS

Subscription center

BACK TO TOP

GEN MAGAZINE

Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Published 21 times a year and with additional exclusive editorial content online, GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.

Subscribe
e-NEWSLETTERS

Add GEN to your Inbox! Subscribe today to our complimentary e-newsletters and stay abreast of the latest biotech news and trends. Click the magnifying glass icon next to a newsletter title to view a sample.
 

All fields are required
Email
Confirm Email
First Name
Last Name
Organization
E-Alert Format
 
 
  Sign Up

ADVERTISEMENT

GEN webinars

« View All Webinars »

ADVERTISEMENT

ADVERTISEMENT

GENpoll

Funding Early-Stage Companies

How much do you think newly established funds will succeed in helping startups?

Suggest a Poll
« More »     « View Results »     « Poll Archive »